Leon Medical Centers Partners with Health Tech Company Rimidi, Reducing A1Cs in High-Risk Cohort of Patients with Type 2 Diabetes
84% of patients being remotely monitored by Leon clinicians using Rimidi’s platform have improved their A1C to below 9%…